6oif - Revision history

OCA at 03:59, 11 April 2020

OCA — Sat, 11 Apr 2020 03:59:53 GMT

←Older revision		Revision as of 03:59, 11 April 2020
Line 3:		Line 3:
	<SX load='6oif' size='340' side='right' viewer='molstar' caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>		<SX load='6oif' size='340' side='right' viewer='molstar' caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6OIF FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6OIF FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene></td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">TOR1A, DQ2, DYT1, TA, TORA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">TOR1A, DQ2, DYT1, TA, TORA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6oif FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oif OCA], [http://pdbe.org/6oif PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oif RCSB], [http://www.ebi.ac.uk/pdbsum/6oif PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oif ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6oif FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oif OCA], [http://pdbe.org/6oif PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oif RCSB], [http://www.ebi.ac.uk/pdbsum/6oif PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oif ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 23:12, 6 March 2020

OCA — Fri, 06 Mar 2020 23:12:37 GMT

←Older revision		Revision as of 23:12, 6 March 2020
Line 1:		Line 1:

	==Cryo-EM structure of human TorsinA filament==		==Cryo-EM structure of human TorsinA filament==
-	<~~StructureSection~~ load='6oif' size='340' side='right'caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>	+	<SX load='6oif' size='340' side='right' viewer='molstar' caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIF FirstGlance]. <br>		<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIF FirstGlance]. <br>
Line 24:		Line 24:
	<references/>		<references/>
	__TOC__		__TOC__
-	</~~StructureSection~~>	+	</SX>
	[[Category: Human]]		[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]

OCA at 06:20, 7 August 2019

OCA — Wed, 07 Aug 2019 06:20:52 GMT

←Older revision		Revision as of 06:20, 7 August 2019
Line 3:		Line 3:
	<StructureSection load='6oif' size='340' side='right'caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>		<StructureSection load='6oif' size='340' side='right'caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIF FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIF FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">TOR1A, DQ2, DYT1, TA, TORA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oif FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oif OCA], [http://pdbe.org/6oif PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oif RCSB], [http://www.ebi.ac.uk/pdbsum/6oif PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oif ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oif FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oif OCA], [http://pdbe.org/6oif PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oif RCSB], [http://www.ebi.ac.uk/pdbsum/6oif PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oif ProSAT]</span></td></tr>
	</table>		</table>
Line 11:		Line 12:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/TOR1A_HUMAN TOR1A_HUMAN]] Protein with chaperone functions important for the control of protein folding, processing, stability and localization as well as for the reduction of misfolded protein aggregates. Involved in the regulation of synaptic vesicle recycling, controls STON2 protein stability in collaboration with the COP9 signalosome complex (CSN). In the nucleus, may link the cytoskeleton with the nuclear envelope, this mechanism seems to be crucial for the control of nuclear polarity, cell movement and, specifically in neurons, nuclear envelope integrity. Participates in the cellular trafficking and may regulate the subcellular location of multipass membrane proteins such as the dopamine transporter SLC6A3, leading to the modulation of dopamine neurotransmission. In the endoplasmic reticulum, plays a role in the quality control of protein folding by increasing clearance of misfolded proteins such as SGCE variants or holding them in an intermediate state for proper refolding. May have a redundant function with TOR1B in non-neural tissues.<ref>PMID:15505207</ref> <ref>PMID:16361107</ref> <ref>PMID:17428918</ref> <ref>PMID:18167355</ref> <ref>PMID:18827015</ref> <ref>PMID:19339278</ref> <ref>PMID:20169475</ref> <ref>PMID:23569223</ref>		[[http://www.uniprot.org/uniprot/TOR1A_HUMAN TOR1A_HUMAN]] Protein with chaperone functions important for the control of protein folding, processing, stability and localization as well as for the reduction of misfolded protein aggregates. Involved in the regulation of synaptic vesicle recycling, controls STON2 protein stability in collaboration with the COP9 signalosome complex (CSN). In the nucleus, may link the cytoskeleton with the nuclear envelope, this mechanism seems to be crucial for the control of nuclear polarity, cell movement and, specifically in neurons, nuclear envelope integrity. Participates in the cellular trafficking and may regulate the subcellular location of multipass membrane proteins such as the dopamine transporter SLC6A3, leading to the modulation of dopamine neurotransmission. In the endoplasmic reticulum, plays a role in the quality control of protein folding by increasing clearance of misfolded proteins such as SGCE variants or holding them in an intermediate state for proper refolding. May have a redundant function with TOR1B in non-neural tissues.<ref>PMID:15505207</ref> <ref>PMID:16361107</ref> <ref>PMID:17428918</ref> <ref>PMID:18167355</ref> <ref>PMID:18827015</ref> <ref>PMID:19339278</ref> <ref>PMID:20169475</ref> <ref>PMID:23569223</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	TorsinA is an ER-resident AAA + ATPase, whose deletion of glutamate E303 results in the genetic neuromuscular disease primary dystonia. TorsinA is an unusual AAA + ATPase that needs an external activator. Also, it likely does not thread a peptide substrate through a narrow central channel, in contrast to its closest structural homologs. Here, we examined the oligomerization of TorsinA to get closer to a molecular understanding of its still enigmatic function. We observe TorsinA to form helical filaments, which we analyzed by cryo-electron microscopy using helical reconstruction. The 4.4 A structure reveals long hollow tubes with a helical periodicity of 8.5 subunits per turn, and an inner channel of ~ 4 nm diameter. We further show that the protein is able to induce tubulation of membranes in vitro, an observation that may reflect an entirely new characteristic of AAA + ATPases. We discuss the implications of these observations for TorsinA function.
		+
		+	The AAA + ATPase TorsinA polymerizes into hollow helical tubes with 8.5 subunits per turn.,Demircioglu FE, Zheng W, McQuown AJ, Maier NK, Watson N, Cheeseman IM, Denic V, Egelman EH, Schwartz TU Nat Commun. 2019 Jul 22;10(1):3262. doi: 10.1038/s41467-019-11194-w. PMID:31332180<ref>PMID:31332180</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6oif" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Demircioglu, F E]]		[[Category: Demircioglu, F E]]

OCA at 06:20, 24 July 2019

OCA — Wed, 24 Jul 2019 06:20:16 GMT

←Older revision		Revision as of 06:20, 24 July 2019
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6oif is ~~ON HOLD until Paper Publication~~	+	==Cryo-EM structure of human TorsinA filament==
-		+	<StructureSection load='6oif' size='340' side='right'caption='[[6oif]], [[Resolution\|resolution]] 4.40Å' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[6oif]] is a 25 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIF FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oif FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oif OCA], [http://pdbe.org/6oif PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oif RCSB], [http://www.ebi.ac.uk/pdbsum/6oif PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oif ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/TOR1A_HUMAN TOR1A_HUMAN]] Myoclonus-dystonia syndrome;Early-onset generalized limb-onset dystonia. The disease is caused by mutations affecting the gene represented in this entry.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/TOR1A_HUMAN TOR1A_HUMAN]] Protein with chaperone functions important for the control of protein folding, processing, stability and localization as well as for the reduction of misfolded protein aggregates. Involved in the regulation of synaptic vesicle recycling, controls STON2 protein stability in collaboration with the COP9 signalosome complex (CSN). In the nucleus, may link the cytoskeleton with the nuclear envelope, this mechanism seems to be crucial for the control of nuclear polarity, cell movement and, specifically in neurons, nuclear envelope integrity. Participates in the cellular trafficking and may regulate the subcellular location of multipass membrane proteins such as the dopamine transporter SLC6A3, leading to the modulation of dopamine neurotransmission. In the endoplasmic reticulum, plays a role in the quality control of protein folding by increasing clearance of misfolded proteins such as SGCE variants or holding them in an intermediate state for proper refolding. May have a redundant function with TOR1B in non-neural tissues.<ref>PMID:15505207</ref> <ref>PMID:16361107</ref> <ref>PMID:17428918</ref> <ref>PMID:18167355</ref> <ref>PMID:18827015</ref> <ref>PMID:19339278</ref> <ref>PMID:20169475</ref> <ref>PMID:23569223</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Demircioglu, F E]]
		+	[[Category: Egelman, E H]]
		+	[[Category: Schwartz, T U]]
		+	[[Category: Zheng, W]]
		+	[[Category: Aaa+ atpase]]
		+	[[Category: Endoplasmic reticulum]]
		+	[[Category: Hydrolase]]
		+	[[Category: Membrane]]
		+	[[Category: Nuclear envelope]]
		+	[[Category: Nucleotide binding]]

OCA at 21:04, 5 June 2019

OCA — Wed, 05 Jun 2019 21:04:10 GMT

←Older revision		Revision as of 21:04, 5 June 2019
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6oif is ON HOLD	+	The entry 6oif is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "6oif" [edit=sysop:move=sysop]

OCA — Wed, 17 Apr 2019 04:13:52 GMT

Protected "6oif" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:13, 17 April 2019

OCA: New page: '''Unreleased structure''' The entry 6oif is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 17 Apr 2019 04:13:50 GMT

New page: '''Unreleased structure''' The entry 6oif is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6oif is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]